NDC properties for NDC 9 0641-6118
NDC item 00641611801
NDC 9 | 0641-6118 |
---|---|
NDC 10 | 0641-6118-01 |
NDC Item | 00641611801 |
packaging | 100 mL in 1 VIAL, PHARMACY BULK PACKAGE (0641-6118-01) |
ANDA | ANDA065403 |
FDA SPL set id | 802596 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-12-03 |
Marketing status | ACTIVE |
NDC item 00641612101
NDC 9 | 0641-6121 |
---|---|
NDC 10 | 0641-6121-01 |
NDC Item | 00641612101 |
packaging | 100 mL in 1 VIAL, PHARMACY BULK PACKAGE (0641-6121-01) |
ANDA | ANDA065403 |
FDA SPL set id | 218755 |
Labeler | West-Ward Pharmaceuticals Corp. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-12-03 |
Marketing status | ACTIVE |
NDC item 00781303446
NDC 9 | 0781-3034 |
---|---|
NDC 10 | 0781-3034-46 |
NDC Item | 00781303446 |
packaging | 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, PHARMACY BULK PACKAGE (0781-3034-46) |
ANDA | ANDA065240 |
FDA SPL set id | 526354 |
Labeler | Sandoz Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2014-06-30 |
Marketing effective time low | 2006-07-25 |
Marketing status | COMPLETED |
NDC item 25021014499
NDC 9 | 25021-144 |
---|---|
NDC 10 | 25021-144-99 |
NDC Item | 25021014499 |
packaging | 1 BOTTLE in 1 CARTON (25021-144-99) / 100 mL in 1 BOTTLE |
ANDA | ANDA065403 |
FDA SPL set id | 537054 |
Labeler | Sagent Pharmaceuticals |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2010-08-12 |
Marketing status | ACTIVE |
NDC item 25021018899
NDC 9 | 25021-188 |
---|---|
NDC 10 | 25021-188-99 |
NDC Item | 25021018899 |
packaging | 1 BOTTLE in 1 CARTON (25021-188-99) / 100 mL in 1 BOTTLE |
ANDA | ANDA090578 |
FDA SPL set id | 549274 |
Labeler | Sagent Pharmaceuticals |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2021-03-31 |
Marketing effective time low | 2017-08-15 |
Marketing status | COMPLETED |
NDC item 44567021201
NDC 9 | 44567-212 |
---|---|
NDC 10 | 44567-212-01 |
NDC Item | 44567021201 |
packaging | 1 VIAL in 1 CARTON (44567-212-01) / 100 mL in 1 VIAL |
ANDA | ANDA065188 |
FDA SPL set id | 802523 |
Labeler | WG Critical Care, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2005-11-25 |
Marketing status | ACTIVE |
NDC item 55150011801
NDC 9 | 55150-118 |
---|---|
NDC 10 | 55150-118-01 |
NDC Item | 55150011801 |
packaging | 1 VIAL, PHARMACY BULK PACKAGE in 1 CARTON (55150-118-01) / 100 mL in 1 VIAL, PHARMACY BULK PACKAGE |
ANDA | ANDA090339 |
COLORTEXT | WHITE(White to Off-white) |
Color | C48325 __ |
FDA SPL set id | 705808 |
FDA SPL set id | 790102 |
Labeler | Eugia US LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-02-10 |
Marketing status | ACTIVE |
NDC item 55150011899
NDC 9 | 55150-118 |
---|---|
NDC 10 | 55150-118-99 |
NDC Item | 55150011899 |
packaging | 1 VIAL, PHARMACY BULK PACKAGE in 1 CARTON (55150-118-99) / 100 mL in 1 VIAL, PHARMACY BULK PACKAGE |
ANDA | ANDA090339 |
COLORTEXT | WHITE(White to Off-white) |
Color | C48325 __ |
FDA SPL set id | 705808 |
FDA SPL set id | 790102 |
Labeler | Eugia US LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-02-10 |
Marketing status | ACTIVE |
NDC item 63323037062
NDC 9 | 63323-370 |
---|---|
NDC 10 | 63323-370-62 |
NDC Item | 63323037062 |
packaging | 10 VIAL in 1 CARTON (63323-370-62) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA065314 |
FDA SPL set id | 440211 |
Labeler | Fresenius Kabi USA, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2016-07-25 |
Marketing effective time low | 2006-11-27 |
Marketing status | COMPLETED |
NDC item 66794020815
NDC 9 | 66794-208 |
---|---|
NDC 10 | 66794-208-15 |
NDC Item | 66794020815 |
packaging | 1 BOTTLE in 1 CARTON (66794-208-15) / 100 mL in 1 BOTTLE |
ANDA | ANDA090578 |
FDA SPL set id | 683048 |
Labeler | Piramal Critical Care Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2023-05-15 |
Marketing effective time low | 2019-05-20 |
Marketing status | COMPLETED |
NDC item 66794024315
NDC 9 | 66794-243 |
---|---|
NDC 10 | 66794-243-15 |
NDC Item | 66794024315 |
packaging | 1 BOTTLE in 1 CARTON (66794-243-15) / 100 mL in 1 BOTTLE |
ANDA | ANDA090578 |
FDA SPL set id | 695618 |
Labeler | Piramal Critical Care Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2023-05-15 |
Marketing effective time low | 2019-05-20 |
Marketing status | COMPLETED |
NDC item 67457064910
NDC 9 | 67457-649 |
---|---|
NDC 10 | 67457-649-10 |
NDC Item | 67457064910 |
packaging | 1 VIAL, PHARMACY BULK PACKAGE in 1 CARTON (67457-649-10) / 92 mL in 1 VIAL, PHARMACY BULK PACKAGE |
ANDA | ANDA202197 |
FDA SPL set id | 675550 |
Labeler | Mylan Institutional LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2023-12-31 |
Marketing effective time low | 2014-04-08 |
Marketing status | COMPLETED |
NDC item 70594008301
NDC 9 | 70594-083 |
---|---|
NDC 10 | 70594-083-01 |
NDC Item | 70594008301 |
packaging | 1 VIAL, PHARMACY BULK PACKAGE in 1 CARTON (70594-083-01) / 100 mL in 1 VIAL, PHARMACY BULK PACKAGE |
ANDA | ANDA090578 |
FDA SPL set id | 685160 |
Labeler | Xellia Pharmaceuticals USA LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2021-01-10 |
Marketing status | ACTIVE |
NDC item 71288000775
NDC 9 | 71288-007 |
---|---|
NDC 10 | 71288-007-75 |
NDC Item | 71288000775 |
packaging | 1 BOTTLE in 1 CARTON (71288-007-75) / 1 INJECTION, POWDER, FOR SOLUTION in 1 BOTTLE |
ANDA | ANDA090578 |
FDA SPL set id | 770217 |
Labeler | Meitheal Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2024-07-31 |
Marketing effective time low | 2018-12-17 |
Marketing status | COMPLETED |
NDC item 71288003375
NDC 9 | 71288-033 |
---|---|
NDC 10 | 71288-033-75 |
NDC Item | 71288003375 |
packaging | 1 BOTTLE in 1 CARTON (71288-033-75) / 1 INJECTION, POWDER, FOR SOLUTION in 1 BOTTLE |
ANDA | ANDA065314 |
FDA SPL set id | 712327 |
FDA SPL set id | 787683 |
Labeler | Meitheal Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2006-11-27 |
Marketing status | ACTIVE |
NDC item 71288003391
NDC 9 | 71288-033 |
---|---|
NDC 10 | 71288-033-91 |
NDC Item | 71288003391 |
packaging | 1 BOTTLE in 1 CARTON (71288-033-91) / 1 INJECTION, POWDER, FOR SOLUTION in 1 BOTTLE |
ANDA | ANDA065314 |
FDA SPL set id | 712327 |
FDA SPL set id | 787683 |
Labeler | Meitheal Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2006-11-27 |
Marketing status | ACTIVE |
NDC item 72603044401
NDC 9 | 72603-444 |
---|---|
NDC 10 | 72603-444-01 |
NDC Item | 72603044401 |
packaging | 10 BOTTLE in 1 CARTON (72603-444-01) / 1 INJECTION, POWDER, FOR SOLUTION in 1 BOTTLE |
ANDA | ANDA065314 |
FDA SPL set id | 793826 |
Labeler | NorthStar Rx, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2024-03-01 |
Marketing status | active |